Clinical Trial: Internet Diabetes Self-Management

This study is not yet open for patient recruitment.
Verified by Stanford University September 2005

Sponsors and Collaborators: Stanford University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: Stanford University
ClinicalTrials.gov Identifier: NCT00185601

Purpose

The purpose of this study is to determine of the effectiveness of an Internet based Diabetes Self-Management workshop for people with type II diabetes. Half of the people who complete the workshop will be invited to continue their education by participating in a email discussion group. Thus, we will be able to learn both the efficacy of the original program as well as its efficacy when reinforced by the discussion group.

Diabetes is a disease that must be managed day by day by the individual with the disease. Although we know a great deal about the self-management of type II diabetes, most self-management is less than optimal. In addition, most people with diabetes do not have an opportunity to participate in formal diabetes education. This study will determine if an Internet delivered educational workshop will help people with diabetes manage their disease. Thus we will be measuring changes in behaviors, changes in symptoms and changes in HbA1c, blood pressure, cholesterol, and weight. If successful the workshop will serve as a prototype for Internet diabetes education.

Condition Intervention Phase
diabetes type 2
 Behavior: Internet Diabetes Self-Management Program
Phase II

MedlinePlus related topics:  Diabetes

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Crossover Assignment, Efficacy Study

Official Title: Internet Diabetes Self-Management: A Randomized Trial

Further Study Details: 
Primary Outcomes: HbA1c
Secondary Outcomes: non-HDL cholesterol index; Health-related quality of life; Health behaviors; Health care utilization
Expected Total Enrollment:  775

Study start: November 2005;  Expected completion: June 2009
Last follow-up: December 2008;  Data entry closure: February 2009

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

Diabetes type 2 Have internet access and email address Live in the United States 18 years of age or older

Exclusion Criteria:

Previous participation in similar online or community-based self-management program Active treatment for cancer Pregnant

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00185601

Diana D Laurent, MPH      650-723-7935    diabetes@med.stanford.edu
Kathryn L Plant, MPH      650-723-7935    diabetes@med.stanford.edu

California
      Leland Stanford Junior University, Department of Medicine, Palo Alto,  California,  94305,  United States
Kate R Lorig, DrPH,  Principal Investigator

Study chairs or principal investigators

Kate Lorig, DrPH,  Principal Investigator,  Stanford University Department of Medicine   
Diana D Laurent, MPH,  Study Director,  Stanford University Department of Medicine   

More Information

Study ID Numbers:  49148; 49148
Last Updated:  September 15, 2005
Record first received:  September 9, 2005
ClinicalTrials.gov Identifier:  NCT00185601
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-20



Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us